Connect with Us
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.
This Webinar series explores how roles and talent management have evolved, what new roles exist or are needed and what skills and competencies are required to succeed in these roles. From the manager’s perspective, we will discuss potential strategies for staying on top of this ever-changing field to manage and retain highly effective teams.
Join us for this exciting webinar where we will discuss groundbreaking innovations in the digital health space aimed at advancing the care of patients now and in the future.
This webinar will discuss the leadership role that Medical Affairs plays in the development and execution of a cross-functional launch plan. An upcoming gene therapy launch will provide real-life examples of how Medical Affairs can be an effective strategic leader through launch planning
In this webinar we’ll explore a new paradigm for engagement planning that is more customer-centric. We’ll share an agile approach focused on shared objectives (rather than siloed interactions) that enable teams to plan, coordinate and review expert engagements across functions and regions.
In this webinar, our presenters will take a Medical Affairs-specific approach to general finance topics, useful for all Medical Affairs functions but particularly operations, therapeutic area leadership, and aspiring Medical Affairs managers.
In this webinar, we’ll share practical techniques for conceptualizing and implementing an Impact and Performance Management Program.
The goal of this webinar is to help new professionals in Medical Affairs better understand how Medical Information and MSLs can have harmonized activities, benefit from one another working more closely together, but also understand where being too close may increase risk.
This in-person Chapter event features two short presentations followed by a networking/cocktail hour.
The goal of this webinar is to enable MedAffairs Organizations and their MSLs to better align and deliver scientific exchange per new KOL expectations, and provide more value through agile & personalized content assembly capability that can empower MSLs.
This Webinar series explores the fundamental concept of big data in Medical Affairs, from which sources can we retrieve this, what are the broader considerations when utilizing data in health and what impact this can have on our organizations, physicians, and patients, now and in the future. These presentations will feature real world cases that are relevant to regional and country Medical Affairs leaders, in order to highlight long-term aspirational and short-term tangible projects
Medical Affairs Career Evolution and Development. Where does MAPS fit in?
This Webinar series explores how roles and talent management have evolved, what new roles exist or are needed and what skills and competencies are required to succeed in these roles. From the manager’s perspective, we will discuss potential strategies for staying on top of this ever-changing field to manage and retain highly effective teams.
This Webinar aims to achieve awareness on challenges and solutions when listening to, and interacting with, Digital Opinion Leaders.
Program Desciption Coming Soon
This webinar will discuss the most recent industry guidance related to patient engagement and share information on a number of industry supported resources, to enable Medical Affairs colleagues to implement patient engagement and evidence strategies. The panel will share updates on latest regulatory requirements, inclusive of PED in FDA and HTA assessments.
This webinar seeks to help Medical Affairs professionals better understand the business of life science companies, how their efforts impact the overall capability to commercialize a product, and contemporary ways to bridge the commercialization interface between their department and Marketing & Sales.
This virtual presentation will focus on 3 aspects of RWE: What are RWE and Real-World Data (RWD), and how are they different? What are relevant legal and regulatory considerations associated with using RWE for product label expansion? How have applicants successfully used RWE to obtain approval for new drug and medical device indications?